Seaport Therapeutics

Last updated: October 22, 2024

CEO - Daphne Zohar
CEO - Daphne Zohar
USA | Funding: $325M (+)

Website: https://seaporttx.com/

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.